Stock Quote
DUSA Pharmaceuticals, Inc (DUSA.W) (NASD ADF)
$1.46
10 Nov 2009
+0.69%
$1.45
$1.46
200
$1.46
$1.46
$1.80
$0.88
0.48
63,105
DUSA.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Haft, Jay | Chairman of the Board | -- |
| Doman, Robert | President, Chief Executive Officer, Director | 951,921 |
| Christopher, Richard | Chief Financial Officer, Vice President - Finance | 400,803 |
Profile
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company developing and marketing Levulan PDT and other products for common skin conditions. The marketed products include among others Levulan Kerastick 20% Topical Solution with photodynamic therapy (PDT), the BLU-U brand... Full Description
Company Address
DUSA Pharmaceuticals, Inc
25 Upton Drive
Wilmington MA 01887
P: +1978.6577500
F: +1978.6579193
25 Upton Drive
Wilmington MA 01887
P: +1978.6577500
F: +1978.6579193
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| QLT Inc. | $3.92 | +0.01 |
| Miravant Medical Technologies | $0.00 | 0.00 |
| Pharmacyclics, Inc. | $1.82 | +0.09 |
| DUSA.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 1.36 | 29.90 |
| ROI(TTM) | -22.75 | 2.35 |
| ROE(TTM) | -28.37 | 3.59 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $6.93M |
| Net Income | $-0.41M |
| EPS | $-0.02 |
